{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:19:42Z","timestamp":1793845182188,"version":"4.6.1"},"reference-count":31,"publisher":"Informa UK Limited","issue":"16","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merus N.V"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/14796694.2025.2511470","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T08:09:17Z","timestamp":1749802157000},"page":"2007-2016","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-9742","authenticated-orcid":false,"given":"Jean-Pascal","family":"Machiels","sequence":"first","affiliation":[{"name":"Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8126-7019","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Fayette","sequence":"additional","affiliation":[{"name":"University of Lyon","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-0079","authenticated-orcid":false,"given":"Robert","family":"Haddad","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-8227","authenticated-orcid":false,"given":"Douglas","family":"Adkins","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine","place":["St. Louis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8145-5749","authenticated-orcid":false,"given":"Maura","family":"Gillison","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6014-348X","authenticated-orcid":false,"given":"Kevin J","family":"Harrington","sequence":"additional","affiliation":[{"name":"The Institute of Cancer Research\/Royal Marsden","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-8332","authenticated-orcid":false,"given":"Sung-Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"University of Ulsan College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-4686","authenticated-orcid":false,"given":"Christophe","family":"Le Tourneau","sequence":"additional","affiliation":[{"name":"Institut Curie","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-766X","authenticated-orcid":false,"given":"Amanda","family":"Psyrri","sequence":"additional","affiliation":[{"name":"National Kapodistrian University of Athens Medical School","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-2987","authenticated-orcid":false,"given":"Ari","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"University of Chicago","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-0540","authenticated-orcid":false,"given":"Lillian L","family":"Siu","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-3106","authenticated-orcid":false,"given":"Makoto","family":"Tahara","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital East","place":["Kashiwa, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-8854","authenticated-orcid":false,"suffix":"Jr","given":"William N.","family":"William","sequence":"additional","affiliation":[{"name":"Grupo Oncocl\u00ednicas","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Ford","sequence":"additional","affiliation":[{"name":"Merus N.V","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekeab","family":"Jauhari","sequence":"additional","affiliation":[{"name":"Clinical Development, Merus N.V., Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Pyle","sequence":"additional","affiliation":[{"name":"Merus N.V","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Shen","sequence":"additional","affiliation":[{"name":"Biostatistics, Merus N.V., Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yao","sequence":"additional","affiliation":[{"name":"Clinical Development, Merus N.V., Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Zohren","sequence":"additional","affiliation":[{"name":"Clinical Development, Merus N.V., Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8645-8068","authenticated-orcid":false,"given":"Everett","family":"Vokes","sequence":"additional","affiliation":[{"name":"University of Chicago Medical Center","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"World Cancer Research Fund [internet]. Worldwide cancer data; 2024 [cited 2025 Mar 10]. Available from: https:\/\/www.wcrf.org\/cancer-trends\/worldwide-cancer-data\/"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7368.822"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16340"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104526"},{"key":"e_1_3_5_7_1","unstructured":"National Comprehensive Cancer Network\u00ae [Internet]. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae). Head and neck cancers. Version 2. 2025 Jan 17 [cited 2025 Feb 14]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.011"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-023-01590-6"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02508"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31999-8"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12155"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2014.01.011"},{"issue":"4","key":"e_1_3_5_15_1","first-page":"1547","article-title":"Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach","volume":"34","author":"Ribeiro FA","year":"2014","unstructured":"Ribeiro FA, Noguti J, Oshima CT, et al. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach. Anticancer Res. 2014;34(4):1547\u20131552.","journal-title":"Anticancer Res"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0202-2"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.235473.113"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21713"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.02.008"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.11.001"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1288-8"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3207"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-013-1721-x"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-4552"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00359-0"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15846-0"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax8313"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.412"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature22081"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09898-0"},{"key":"e_1_3_5_31_1","unstructured":"ClinicalTrials.gov [Internet]. A study of bispecific antibody MCLA-158 in patients with advanced solid tumors. NCT03526835. 2025 Jan 29 [cited 2025 Mar 7]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03526835"},{"key":"e_1_3_5_32_1","volume-title":"Oral presented at: American Society of Clinical Oncology Annual Meeting; 2024 May 31\u2013Jun 4","author":"Fayette J","unstructured":"Fayette J, Clatot F, Bra\u00f1a I, et al. Petosemtamab (MCLA-158) with pembrolizumab as first-line (1L) treatment of recurrent\/metastatic (r\/m) head and neck squamous cell carcinoma (HNSCC): phase 2 study. In: Oral presented at: American Society of Clinical Oncology Annual Meeting; 2024 May 31\u2013Jun 4; Chicago, IL; [cited 2025 May 7]. https:\/\/merus.nl\/wp-content\/uploads\/2024\/06\/MCLA-158-oral-ASCO2024-FINAL.pdf."},{"key":"e_1_3_5_33_1","volume-title":"Oral presented at: European Society for Medical Oncology Asia Annual Meeting; 2024 Dec 6\u20138","author":"Le Tourneau C","unstructured":"Le Tourneau C, Fayette J, Even C, et al. Petosemtamab (MCLA-158) monotherapy in previously treated (2L+) recurrent\/metastatic (r\/m) head and neck squamous cell carcinoma (HNSCC): phase 2 trial. Oral presented at: European Society for Medical Oncology Asia Annual Meeting; 2024 Dec 6\u20138; Singapore, Republic of Singapore. https:\/\/merus.nl\/wp-content\/uploads\/2024\/12\/FPN411MO-ESMO-Asia_Peto_F3.pdf"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2511470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T14:21:27Z","timestamp":1763043687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2511470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":31,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/14796694.2025.2511470"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2511470","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}